Stockreport

Arcus Biosciences Secures Up to $250 Million Term Loan Facility from Hercules Capital

Arcus Biosciences, Inc.  (RCUS) 
Last arcus biosciences, inc. earnings: 3/5 04:10 pm Check Earnings Report
PDF Facility adds operational flexibility and provides funding for the recently announced Phase 3 PEAK-1 study for casdatifan.$150 million committed, of which $50 million wa [Read more]